Literature DB >> 8491998

Quantitative angiographic follow-up studies on the development of coronary artery disease: which coronary segments should be analyzed? Experience from INTACT.

S Jost1, J Deckers, W Rafflenbeul, J H Reiber, P Nikutta, B Wiese, H Hecker, P Lippolt, M Riedel, C W Nolte.   

Abstract

Angiographic follow-up studies on the evolution of coronary artery disease are of increasing relevance. It has still to be evaluated which coronary segments are predominantly involved in the process of atherosclerosis and, thus, should be preferably included in the analysis. Therefore, the correlation of progression and regression of coronary disease with the diameter and location (proximal, mid or distal) of coronary segments was investigated from the data of the INTACT-study, in which 25 different coronary segments were defined including anatomic variants of rather distal segments. In 348 patients with coronary artery disease, standardized coronary angiograms were repeated within 3 years and were quantitatively analyzed (CAAS). In 1063 coronary stenoses (% diameter stenosis > 20%) compared from both angiograms, progression and regression were not influenced by diameter nor location of arterial segments. In the follow-up angiograms, the number of new lesions (stenoses and occlusions) per coronary segment differed with regard to segment diameter (> 3 mm: 64/1125 (6%); 2-3 mm: 139/1967 (7%); < 2 mm: 44/1756 (2%); p < 0.001) and location of segments (proximal: 86/1285 (7%); mid: 84/1193 (7%); distal: 77/2370 (3%); p < 0.001). Out of 77 distal new lesions, only 25 (32%) were found in segments < 2 mm in diameter. Since the absolute number of new lesions was high in distal coronary segments, but low in segments with diameters < 2 mm, angiographic follow-up studies should analyze coronary segments at any location, but may neglect segments with diameters smaller than 2 mm.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491998     DOI: 10.1007/BF01142930

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  42 in total

1.  A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.

Authors:  D Waters; J Lespérance; M Francetich; D Causey; P Théroux; Y K Chiang; G Hudon; L Lemarbre; M Reitman; M Joyal
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

2.  Features of the angiographic evaluation of the INTACT study. International Nifedipine Trial on Antiatherosclerotic Therapy.

Authors:  S Jost; J Deckers; W Rafflenbeul; H Hecker; U Nellessen; B Wiese; P G Hugenholtz; P R Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

3.  The natural history of coronary artery stenosis. A longitudinal angiographic assessment.

Authors:  J Rösch; R Antonovic; R S Trenouth; S H Rahimtoola; D N Sim; C T Dotter
Journal:  Radiology       Date:  1976-06       Impact factor: 11.105

4.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

5.  Clinical application of quantitative coronary angiography using the CAAS system: preliminary results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).

Authors:  S Jost; J W Deckers; U Nellessen; W Rafflenbeul; H Hecker; J H Reiber; P G Hugenholtz; P R Lichtlen
Journal:  Int J Card Imaging       Date:  1988

6.  Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study.

Authors:  L H Kushi; R A Lew; F J Stare; C R Ellison; M el Lozy; G Bourke; L Daly; I Graham; N Hickey; R Mulcahy
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245

7.  Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial.

Authors:  A C Arntzenius; D Kromhout; J D Barth; J H Reiber; A V Bruschke; B Buis; C M van Gent; N Kempen-Voogd; S Strikwerda; E A van der Velde
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245

8.  Drug plasma levels and coronary vasodilation after isosorbide dinitrate chewing capsules.

Authors:  S Jost; W Rafflenbeul; I Knop; C Bossaller; D Gulba; H Hecker; P Lippolt; P R Lichtlen
Journal:  Eur Heart J       Date:  1989-11       Impact factor: 29.983

9.  [Progression of coronary sclerosis. Studies in 19 patients over a 6-year period using quantitative coronary angiography].

Authors:  U Nellessen; W Rafflenbeul; H Hecker; P Lichtlen
Journal:  Z Kardiol       Date:  1984-12

10.  Attenuation of the media of coronary arteries in advanced atherosclerosis.

Authors:  J M Isner; R F Donaldson; A H Fortin; A Tischler; R H Clarke
Journal:  Am J Cardiol       Date:  1986-11-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.